Suppr超能文献

疑似或确诊 COVID-19 感染血液透析患者的管理:来自西班牙肾脏病学会的观点。

Management of Hemodialysis Patients with Suspected or Confirmed COVID-19 Infection: Perspective from the Spanish Nephrology.

机构信息

Department of Nephrology, Hospital Universitario de Cabueñes, Oviedo, Spain.

Department of Nephrology, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.

出版信息

Kidney360. 2020 Sep 11;1(11):1254-1258. doi: 10.34067/KID.0002602020. eCollection 2020 Nov 25.

Abstract

BACKGROUND

The recent SARS-CoV-2 coronavirus pandemic has signified a significant effect on the health of the population worldwide. Patients on chronic RRT have been affected by the virus, and they are at higher risk due to the frequent comorbid conditions. Here, we show the results of the COVID-19 Registry of the Spanish Society of Nephrology during the first 6 weeks of the outbreak.

METHODS

This study is an analysis of the data recorded on a registry of patients with ESKD on RRT who tested positive for COVID-19. The aim was to evaluate clinical conditions, therapeutic management, and consequences, including outcome. The registry began on March 18th, 2020. It includes epidemiologic data, cause of CKD, signs and symptoms of the infection, treatments, and outcomes. Patients were diagnosed with SARS-CoV-2 infection on the basis of the results of PCR of the virus obtained from nasopharyngeal/oropharyngeal swabs. The tests were performed on symptomatic patients and on those who mentioned contact with infected patients.

RESULTS

As of May 2, the registry included data on 1397 patients (in-center hemodialysis [IC-HD], 63%; kidney transplant [Tx], 34%; peritoneal dialysis [PD], 3%; and home hemodialysis, 0.3%). The mean age was 67±15 years, and two-thirds were men. Dialysis vintage was 46±41 months, and the time after transplantation was 59±54 months. Eighty-five percent of the patients required hospital admission, and 8% had to be transferred to intensive care units. Overall mortality was 25% (IC-HD, 27%; Tx, 23%; and PD, 15%), and significant proportions of deceased patients have advanced age, are on IC-HD, and presented pneumonia. Age and pneumonia were independently associated with the risk of death.

CONCLUSIONS

SARS-CoV-2 infection affected a significant number of Spanish patients on RRT, mainly those on IC-HD. Hospitalization rates and mortality were high. The factors more closely related to mortality were age and pneumonia.

摘要

背景

最近的 SARS-CoV-2 冠状病毒大流行对全球人口健康产生了重大影响。接受慢性肾脏替代治疗(RRT)的患者受到了该病毒的影响,由于常合并多种疾病,他们的风险更高。在这里,我们展示了西班牙肾脏病学会 COVID-19 登记处在前 6 周爆发期间的结果。

方法

这是一项对接受 RRT 的接受慢性肾脏替代治疗的终末期肾病(ESKD)患者的 COVID-19 检测呈阳性的患者的登记数据进行分析的研究。目的是评估临床状况、治疗管理和后果,包括结局。该登记处于 2020 年 3 月 18 日开始。它包括流行病学数据、CKD 的病因、感染的症状和体征、治疗方法和结局。根据从鼻咽/口咽拭子中获得的病毒的 PCR 结果,对患者进行 SARS-CoV-2 感染的诊断。对有症状的患者和与感染患者有接触的患者进行了检测。

结果

截至 5 月 2 日,登记处包括了 1397 名患者的数据(中心血液透析[IC-HD],占 63%;肾移植[Tx],占 34%;腹膜透析[PD],占 3%;和家庭血液透析,占 0.3%)。平均年龄为 67±15 岁,三分之二为男性。透析年龄为 46±41 个月,移植后时间为 59±54 个月。85%的患者需要住院治疗,8%的患者需要转入重症监护病房。总体死亡率为 25%(IC-HD,27%;Tx,23%;PD,15%),且大量死亡患者年龄较大,接受 IC-HD 治疗,并出现肺炎。年龄和肺炎与死亡风险独立相关。

结论

SARS-CoV-2 感染影响了西班牙接受 RRT 的大量患者,主要是接受 IC-HD 的患者。住院率和死亡率很高。与死亡率更密切相关的因素是年龄和肺炎。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df93/8815506/e2232f910d62/KID.0002602020absf1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验